13.5 C
Glasgow
Saturday, September 27, 2025
spot_img

More News

Kalexo Bio formed to advance siRNA therapy for cardiovascular disorders

Jim Cornall -
Mabwell (Shanghai) Bioscience Co., Ltd. and Aditum Bio have launched Kalexo Bio, a new company formed in conjunction with...

First liquid ambient temperature stable qPCR master mixes

Jim Cornall -
The Life Science division of Meridian Bioscience, Inc. has launched the industry's first liquid qPCR master mixes proven stable...

Lilly to build $5bn manufacturing facility in Virginia

Jim Cornall -
Eli Lilly and Company plans to build a $5bn manufacturing facility just west of Richmond, Virginia, in Goochland County. The...

IND clearance for long QT syndrome treatment

Jim Cornall -
The U.S. Food and Drug Administration (FDA) has cleared Thryv Therapeutics Inc.’s Investigational New Drug (IND) application for its...

Positive results from pivotal Alexander disease study

Jim Cornall -
Ionis Pharmaceuticals, Inc. has announced positive topline results from the pivotal study of zilganersen in children and adults living...

Pfizer to acquire Metsera and its obesity portfolio

Jim Cornall -
Pfizer Inc. and Metsera, Inc. have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage...

New options for lung cancer research with digital cell twin

Jim Cornall -
An enhanced computer model is now helping to provide fresh insights into cancer-cell growth and how it can be...

Possible breakthrough in development of effective biomaterials

Jim Cornall -
Many hopes rested on tissue engineering. With the help of stem cells, skin and other organs could be grown,...

NeuroSense drug candidate shows benefit in Alzheimer’s

Jim Cornall -
NeuroSense Therapeutics Ltd. has announced positive initial results from its collaboration with NeuroKaire in the ongoing RoAD phase 2...

Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms

Jim Cornall -
This week, we have two interviews: one to mark Childhood Cancer Awareness Month, on osteosarcoma with Paul Romness from...

New biosensor detects viruses in the air

Jim Cornall -
A research team from Universitat Politècnica de València (UPV) and Universitat de València (UV) in Spain has developed a...

Cancer’s energy secrets could lead to new treatments

Jim Cornall -
A research group led by The University of Osaka in Japan has developed a novel method for analysing cancer...

New Lithuanian oxygen sensors could lead to scientific breakthroughs

Jim Cornall -
Researchers at Kaunas University of Technology (KTU) in Lithuania have developed new organic compounds that act as highly sensitive...

Galimedix Therapeutics completes phase 1 Alzheimer’s oral small molecule study

Jim Cornall -
Galimedix Therapeutics, Inc. has announced the completion of its phase 1 study with orally administered GAL-101, a small molecule...

XingImaging and SynuSight awarded Michael J. Fox Foundation grant

Jim Cornall -
XingImaging in partnership with SynuSight Biotech has received funding of $3.84m from The Michael J. Fox Foundation to conduct...

New data from non-small cell lung cancer trial

Jim Cornall -
Nuvalent, Inc. has presented pivotal data for zidesamtinib, a novel investigational ROS1-selective inhibitor, in TKI (tyrosine kinase inhibitor) pre-treated...

Kling Bio validates B-cell technology against emerging viral variants

Jim Cornall -
Kling Bio has announced the publication of a peer-reviewed study titled ‘Immune counter-evolution: Immortalized B cell clones can undergo...

iOnctura expands oncology trials to US

Jim Cornall -
iOnctura, a clinical-stage precision oncology company focused on neglected and hard-to-treat cancers, has expanded its clinical trial programme for...

Giant DNA called inocles discovered in the mouth

Jim Cornall -
Researchers including those at the University of Tokyo have made a surprising discovery hiding in people’s mouths: Inocles, giant...

Nanobodies Against Cancer research project

Jim Cornall -
Cancer cells have many strategies for resisting therapy. One is survivin, a protein that drives the division of diseased...

Polyrizon reports successful intranasal delivery of allergy blocker

Jim Cornall -
Polyrizon Ltd. has announced encouraging preclinical results supporting the performance of its PL-14 Allergy Blocker, part of its proprietary...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media